iNtRON Biotechnology of Korea has patented of its composition for the treatment of ballast water containing bacteriophage as an effective component and biological method of removing bacteria present in ballast water with the composition, according to its regulatory filing on December 11.
iNtRON said its one of core technologies, Bacteriophage Therapy Technology was a basis for the ballast water treatment system segment.
The company plans to promote new business related to BWTS by using the US-registered patented product in cooperation with offshore and shipbuilding companies.
Published : December 12, 2012
Komec B2B Marketplace: www.shipsol.com
Chinese Blog : blog.sina.com.cn/komec
General Support: +82-51-972-6474, +82-51-972-6478